Table 6. Distribution of Candida species isolated from candidaemia patients in different studies reported from the Middle East.

Reference	Study period	Country	No. of isolates	% Distribution of Candida species						% Ratio C. albicans/ non albicans
				C. albicans	C. parapsilosis	C. tropicalis	C. glabrata	C. krusei	Others
Rennert et al. [36]	1994	Israel	298	53.6	11.9	10.9	6.5	0.7	15.9	53.6/45.9
Bukharie [37]	1995–2000	Saudi Arabia	32	19	44	25	3	6	3	19/81
Ellis et al. [38]	1995–2001	UAE	60	45	5	15	5	0	30	45/55
Al-Jasser & Elkhizzi [39]	1996–2002	Saudi Arabia	294	50.7	10.9	20.7	7.1	7.8	3.1	50.7/49.6
Al-Sweih et al. [12]	1997–2006	Kuwait	153	41.2	49	-	1.3	-	8.49	41.2/58.79
Osoba et al. [40]	1998–2002	Saudi Arabia	83	46	10.8	10.8	4.8	6	21.6	46/54
Al-Essa et al. [41]	1997	Kuwait	22	31.8	13.7	-	-	-	54.5	31.8/68.2
Mokaddas et al. [42]	1994–1998	Kuwait	25	56	28	8	8	-	10.8	56/54.8
Mokaddas et al. [8]	1996–2005	Kuwait	607	39.5	30.6	12.4	5.6	1.6	11.8	39.5/62
Taj-Aldeen et al. [43]	2004–2010	Qatar	201	33.8	20.8*	17.9	18.9	-	8.5	33.8/45.3
Eliakim-raz et al. [44]	2007–2014	Israel	118**	44	15.2	13.5	23.7	0.8	2.54	44/55.74
Vaezi et al. [45]	until 2015	Iran	55	27.2	30.9	14.5	18.1	-	9	27.2/72.5
Obaid & Khan [46]	2014–2016	Kuwait	82	32	32	20	13	-	3.65	32/68.65
Taj-Aldeen et al. [47]	2009–2014	Qatar	301	30.2	17.9	17.9	25.5	-	8.3	30.2/69.6
Present study	2006–2011	Kuwait	970	41.75	34.2	12.98	7.8	1.54	-	41.75/56.52
	2012–2017		1105	32.8	40.72	13.57	10.4	1.44	-	32.8/66.13

*Includes 8 isolates of C. orthopsilosis;

**Includes population of >18 years; United Arab Emirates (UAE)